No Data
No Data
TD Cowen Maintains AN2 Therapeutics(ANTX.US) With Hold Rating
Here's Why We're Watching AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Situation
AN2 Therapeutics, Inc. (ANTX) Receives a Sell From Evercore ISI
JMP Securities Maintains AN2 Therapeutics(ANTX.US) With Buy Rating, Maintains Target Price $5
Express News | Citizens Capital Markets Reiterates Market Outperform on AN2 Therapeutics, Maintains $5 Price Target
JMP Maintains AN2 Therapeutics Stock With $5 Target